Up a level |
Robinson, Ryan E, Mitsi, Elena, Nikolaou, Elissavet, Pojar, Sherin, Chen, Tao ORCID: 0000-0002-5489-6450, Reine, Jesus, Nyazika, Tinashe K, Court, James, Davies, Kelly, Farrar, Madlen et al (show 24 more authors)
(2022)
Human Infection Challenge with Serotype 3 Pneumococcus.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206 (11).
pp. 1379-1392.
Whitfield, Thomas, Fernandez, Cristina, Davies, Kelly, Defres, Sylviane, Griffiths, Michael, Hooper, Cory, Tangney, Rebecca, Burnside, Girvan ORCID: 0000-0001-7398-1346, Rosala-Hallas, Anna ORCID: 0000-0001-8012-9995, Moore, Perry et al (show 10 more authors)
(2021)
Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis.
BMJ open, 11 (7).
e041808-e041808.
Liatsikos, Konstantinos, Hyder-Wright, Angela, Pojar, Sherin, Chen, Tao ORCID: 0000-0002-5489-6450, Wang, Duolao, Davies, Kelly, Myerscough, Christopher, Reine, Jesus, Robinson, Ryan E, Urban, Britta et al (show 12 more authors)
(2022)
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2).
BMJ Open, 12 (7).
e062109-e062109.
Hazenberg, Phoebe, Robinson, Ryan E, Farrar, Madlen, Solorzano, Carla, Hyder-Wright, Angela, Liatsikos, Konstantinos, Brunning, Jaye, Fleet, Hannah, Bettam, Amy, Howard, Ashleigh et al (show 9 more authors)
(2024)
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3).
BMJ open, 14 (1).
e075948-e075948.
Fyles, Fred, Hill, Helen, Duncan, Gregory, Carter, Emma, Solorzano, Carla, Davies, Kelly, McLellan, Lauren, Lesosky, Maia, Dodd, James, Finn, Adam et al (show 7 more authors)
(2023)
Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK.
BMJ OPEN RESPIRATORY RESEARCH, 10 (1).
e001457.